NASDAQ:MRNA | Free Cash Flow | Moderna, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2016-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$630M$62M-$692M
2025-12-31$930M$39M$891M
2025-03-31-$1.04B$117M-$1.15B
2024-12-31$825M$522M$303M
2024-03-31-$989M$196M-$1.19B
2023-12-31$622M$220M$402M185.25%
2023-03-31-$1.23B$113M-$1.34B-1693.67%
2022-12-31$1.66B$92M$1.57B107.17%
2022-03-31$2.76B$132M$2.63B71.94%
2021-12-31$3.31B$120M$3.19B65.53%
2021-03-31$2.97B$35M$2.94B240.46%
2020-12-31$1.26B$24M$1.24B
2020-03-31-$106M$6M-$112M
2019-12-31-$99.05M$7.11M-$106.16M
2019-03-31-$144.27M$7.6M-$151.86M
2018-12-31-$91.02M$13.64M-$104.66M
2018-03-31-$111.39M$31.91M-$143.29M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$1.87B$192M-$2.07B
2024-12-31-$3B$1.05B-$4.06B
2023-12-31-$3.12B$707M-$3.83B
2022-12-31$4.98B$400M$4.58B54.78%
2021-12-31$13.62B$284M$13.34B109.29%
2020-12-31$2.03B$68M$1.96B
2019-12-31-$459M$32M-$491M
2018-12-31-$330.87M$105.77M-$436.63M
2017-12-31-$331.48M$58.4M-$389.89M
2016-12-31$66.73M$33.14M$33.59M